Lyka Labs jumps after getting CDSCO nod for diabetic drug 0 15.10.2024 09:42 Business Standard Lyka Labs rallied 4.65% to Rs 156.50 after the company received the Central Drug Standard Control Organisation (CDSCO) approval for manufacturing and marketing Pregabalin Gel for the use in patients with Diabetic Neuropathic Pain. Moscow.media Частные объявления сегодня Rss.plus Все новости за 24 часа
